BioNtech can make mutation-beating vaccine in 6 weeks: business chief

BioNTech's Chief Business Officer tells AFP that the company is "absolutely delighted" by the EU's approval of the vaccine. BioNtech says that thanks to the mRNA technology, it can have a new vaccine ready "in six weeks" if necessary against the mutated strain detected in Britain.